Company Profiles

driven by the PitchBook Platform

Lycera

Description

Developer of molecule therapies and drugs for the treatment of autoimmune diseases and cancer. The company engages in research and development of drugs for the treatment of diseases such as psoriasis, rheumatoid arthritis, lupus erythematosis, inflammatory bowel disease, cancer and other autoimmune disease.

2006

Founded

PRIVATE

Status

51-200

Employees

Series B

Latest Deal Type

$29.9M

Latest Deal Amount

$115M

Total Amount Raised

Description

Developer of molecule therapies and drugs for the treatment of autoimmune diseases and cancer. The company engages in research and development of drugs for the treatment of diseases such as psoriasis, rheumatoid arthritis, lupus erythematosis, inflammatory bowel disease, cancer and other autoimmune disease.

Website:

www.lycera.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

2800 Plymouth Road NCRC, Building 26 Ann Arbor, MI 48109United States +1 (734) 233-3060
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Lycera's full profile, request a free trial.

Lycera Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Lycera Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Lycera Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
ARCH Venture PartnersVenture CapitalMinority000 0000000 0000
Clarus VenturesVenture CapitalMinority000 0000000 0000
EDF VenturesVenture CapitalMinority000 0000000 0000
InterWest PartnersVenture CapitalMinority000 0000000 0000
Michigan Investment in New Technology StartupsVenture CapitalMinority000 0000000 0000
ARCH Venture Partners Venture Capital
Clarus Ventures Venture Capital
EDF Ventures Venture Capital
InterWest Partners Venture Capital
Michigan Investment in New Technology Startups Venture Capital

Lycera Executive Team (11)

NameTitleBoard
Seat
Contact
Info
Paul SekhriPresident, Chief Executive Officer & Board Member
Alex HowarthChief Financial Officer
Bruce Goldsmith Ph.DChief Operating Officer and Chief Business Officer
Laura CarterSenior Vice President, Biology
Peter Toogood Ph.DSenior Vice President of Chemistry and Chemical Biology
Paul Sekhri President, Chief Executive Officer & Board Member
Alex Howarth Chief Financial Officer
Bruce Goldsmith Ph.D Chief Operating Officer and Chief Business Officer
Laura Carter Senior Vice President, Biology
Peter Toogood Ph.D Senior Vice President of Chemistry and Chemical Biology

Lycera Board Members (11)

NameRepresentingRoleSinceContact
Info
Finny Kuruvilla Ph.DClarus VenturesPrincipal000 0000
Jeffrey Leiden MDClarus VenturesSenior Advisor000 0000
Kristina BurowARCH Venture PartnersManaging Director000 0000
Mary CampbellEDF VenturesFounder & Managing Director000 0000
Michael HaydenSelfBoard Member000 0000
Finny Kuruvilla Ph.D Principal Clarus Ventures
Jeffrey Leiden MD Senior Advisor Clarus Ventures
Kristina Burow Managing Director ARCH Venture Partners
Mary Campbell Founder & Managing Director EDF Ventures
Michael Hayden Board Member Self
Request full access to PitchBook